Acute Myocardial Infarction (AMI) Clinical Trial
— RESILIENTOfficial title:
Rehabilitation in the Home Setting for Older Adults In the Early Period After Myocardial Infarction
NCT number | NCT02804906 |
Other study ID # | 16-00554 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | June 2016 |
Est. completion date | January 14, 2019 |
Verified date | January 2020 |
Source | NYU Langone Health |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This pilot feasibility study will test whether a home-based cardiac rehabilitation intervention, using physical therapist visits combined with mobile health technology, will prevent decline in high-risk patients post acute myocardial infarction (AMI). Participants will be randomized to either an intervention arm (home-based physical therapy), or a control (usual care) arm. Prior to discharge, participants in the intervention arm will receive a 1-hour educational session by a research physical therapist that includes information on cardiac risk factor management, postoperative recovery, education on medication adherence, and a prescription for home exercise that is tailored to each patient's baseline abilities and limitations. Participants assigned to the control arm will receive a 30-minute counseling session on risk factor modification prior to discharge, in addition to usual care post-AMI.
Status | Completed |
Enrollment | 27 |
Est. completion date | January 14, 2019 |
Est. primary completion date | December 14, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 70 Years and older |
Eligibility |
Inclusion Criteria: - Clinical diagnosis of acute myocardial infarction (AMI). Exclusion Criteria: - moderate to severe cognitive impairment; non-ambulatory - severe heart failure (NYHA Class IV); decisional impairment as assessed by the University of California - San Diego Brief Assessment of Capacity to Consent (UBACC) 22, if the RC questions capacity; very limited life expectancy (e.g. anticipated discharge to hospice) - non-English/non-Spanish speaking. |
Country | Name | City | State |
---|---|---|---|
United States | New York University School of Medicine | New York | New York |
Lead Sponsor | Collaborator |
---|---|
NYU Langone Health |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Activities of Daily Living (ADL) Decline | Assessment of the functional dependence or independence in carrying out activities of daily living, including bathing, dressing, toileting, transferring, continence, and feeding. | 5 Weeks | |
Secondary | Decline in self-perceived physical health (measured by SF-12 PCS) | Health status measure that addresses both physical and mental health. | 5 Weeks | |
Secondary | Mean time spent in sedentary activity | 5 Weeks | ||
Secondary | Mortality Rate | 5 Weeks | ||
Secondary | Hospital readmission rate | 5 Weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01463475 -
University of Wisconsin hMSC Cell Bank: Bone Marrow Donor Protocol
|
N/A | |
Completed |
NCT02290080 -
Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers
|
Phase 3 | |
Completed |
NCT00211172 -
HMO Research Network CERT: Acute Myocardial Infarction
|
N/A | |
Completed |
NCT03725826 -
Risk Stratification After Acute Myocardial Infarction With Cardiac MRI
|
||
Not yet recruiting |
NCT06118281 -
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
|
Phase 3 | |
Completed |
NCT01890018 -
Partners and Alerts: A Study of Social Forces in Medication Adherence
|
N/A | |
Completed |
NCT05696379 -
Angiography Derived Index of Microcirculatory Resistance in Patients With Acute Myocardial Infarction
|
||
Recruiting |
NCT02018497 -
Essential Hypotension and Allostasis Registry
|
||
Completed |
NCT00833612 -
Counterpulsation Reduces Infarct Size Pre-PCI for AMI
|
Phase 4 | |
Completed |
NCT00781118 -
AngelMed for Early Recognition and Treatment of STEMI
|
Phase 3 | |
Not yet recruiting |
NCT04835207 -
Metabolic Profile as a Predictor of No-reflow in Diabetic Patients
|